Telomerase inhibitor imetelstat kills AML cells via lipid ROS and ferroptosis

被引：0

作者：

机构：

来源：

Nature Cancer | 2024年 / 5卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Imetelstat is a first-in-class telomerase inhibitor with efficacy in a number of blood cancers. Intriguingly, telomere lengths do not predict patient responses to imetelstat. We now show that imetelstat causes cell death by a mechanism that involves two regulators of fatty acid metabolism (FADS2 and ACSL4), driving excessive lipid reactive oxygen species formation and ferroptosis.

引用

页码：12 / 13

页数：1

共 50 条

[21] The telomerase inhibitor imetelstat alone, and in combination with trastuzumab, decreases the cancer stem cell population and self-renewal of HER2+ breast cancer cells
Koziel, Jillian E.
Herbert, Brittney-Shea
BREAST CANCER RESEARCH AND TREATMENT, 2015, 149 (03) : 607 - 618
[22] Piperlongumine selectively kills hepatocellular carcinoma cells and preferentially inhibits their invasion via ROS-ER-MAPKs-CHOP
Chen, Yong
Liu, Ju Mei
Xiong, Xin Xin
Qiu, Xin Yao
Pan, Feng
Liu, Di
Lan, Shu Jue
Jin, Si
Yu, Shang Bin
Chen, Xiao Qian
ONCOTARGET, 2015, 6 (08) : 6406 - 6421
[23] Short-term treatment with imetelstat sensitizes hematopoietic malignant cells to a genotoxic agent via suppression of the telomerase-mediated DNA repair process
Hidaka, Daisuke
Onozawa, Masahiro
Miyashita, Naohiro
Yokoyama, Shota
Nakagawa, Masao
Hashimoto, Daigo
Teshima, Takanori
LEUKEMIA & LYMPHOMA, 2020, 61 (11) : 2722 - 2732
[24] Novel Nanomolar Potency Mitochondrial Complex I Inhibitor Iacs-1131 Selectively Kills Oxphos-Dependent AML Cells
Matre, Polina
Protopopova, Marina
Feng, Ningping
Gay, Jason
Greer, Jennifer
Velez, Juliana
Mu, Hong
Lodi, Alessia
Tadi, Surendar
Sweeney, Shannon
Andreeff, Michael
Tiziani, Stefano
DiFrancesco, M. Emilia
Marszalek, Joseph
Konopleva, Marina
BLOOD, 2014, 124 (21)
[25] Clobetasol propionate, a Nrf-2 inhibitor, sensitizes human lung cancer cells to radiation-induced killing via mitochondrial ROS-dependent ferroptosis
Rai, Archita
Patwardhan, Raghavendra S.
Jayakumar, Sundarraj
Pachpatil, Pradnya
Das, Dhruv
Panigrahi, Girish Ch.
Gota, Vikram
Patwardhan, Sejal
Sandur, Santosh K.
ACTA PHARMACOLOGICA SINICA, 2024, 45 (07) : 1506 - 1519
[26] The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML
Zhou, Jianbiao
Bi, Chonglei
Cheong, Lip-Lee
Mahara, Sylvia
Liu, Shaw-Cheng
Tay, Kian-Ghee
Koh, Tze-Loong
Yu, Qiang
Chng, Wee-Joo
BLOOD, 2011, 118 (10) : 2830 - 2839
[27] The telomerase inhibitor imetelstat differentially targets JAK2V617F versus CALR mutant myeloproliferative neoplasm cells and inhibits JAK-STAT signaling
Olschok, Kathrin
Altenburg, Bianca
de Toledo, Marcelo A. S.
Maurer, Angela
Abels, Anne
Beier, Fabian
Gezer, Deniz
Isfort, Susanne
Paeschke, Katrin
Bruemmendorf, Tim H.
Zenke, Martin
Chatain, Nicolas
Koschmieder, Steffen
FRONTIERS IN ONCOLOGY, 2023, 13
[28] Camalexin Induces Apoptosis via the ROS-ER Stress-Mitochondrial Apoptosis Pathway in AML Cells
Yang, Yang
Wang, Gang
Wu, Wenjun
Yao, Shunnan
Han, Xiaoyan
He, Donghua
He, Jingsong
Zheng, Gaofeng
Zhao, Yi
Cai, Zhen
Yu, Rui
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2018, 2018
[29] Role of protein disulfide isomerase in mediating sulfasalazine-induced ferroptosis in HT22 cells: The PDI-NOS-NO- ROS/lipid-ROS cascade
Wu, Yufei
Zhu, Bao Ting
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2025, 768
[30] The Telomerase Inhibitor RHPS4 Induces Telomere Shortening, DNA-Damage and Cell Death in AML Cells and Chemosensitises Cells to Daunorubicin.
Pallis, Monica
Ojo, Dotun
Richardson, Jaineeta
Ronan, John
Stevens, Malcolm
Russell, Nigel H.
Seedhouse, Claire
BLOOD, 2009, 114 (22) : 1079 - 1079

← 1 2 3 4 5 →